➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Colorcon
Express Scripts
McKesson
Baxter

Last Updated: September 20, 2020

DrugPatentWatch Database Preview

Patent: 7,371,928

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,371,928
Title:Plant seed-specific expression promoter derived from sesame and seed-specific expression vector comprising the promoter
Abstract: Provided are a seed-specific expression promoter derived from sesame microsomal oleic acid desaturase (Si-FAD2) gene, an intron for expression enhancement, a seed-specific expression vector including the promoter and/or the intron, and a transgenic plant transformed with the seed-specific expression vector. Therefore, a useful product can be produced in a seed-specific manner or a common product in a seed can be functionally modified. Also, the promoter can be used together with the intron for expression enhancement, thereby increasing the expression level of an inserted gene in a seed. Therefore, it is very useful in development of a transgenic plant which induces large-scale expression of a foreign gene in a seed-specific manner.
Inventor(s): Suh; Mi-Chung (Seoul, KR), Kim; Mi-Jung (Seoul, KR), Kim; Hee-Ja (Seoul, KR), Chung; Chung-Han (Busan, KR), Pyee; Jae-Ho (Gunpo, KR), Hyung; Nam-In (Cheonan, KR)
Assignee: Korea Chungang Educational Foundation (Seoul, KR)
Application Number:10/534,128
Patent Claims:see list of patent claims

Details for Patent 7,371,928

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Korea Chungang Educational Foundation (Seoul, KR) 2022-11-11 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Korea Chungang Educational Foundation (Seoul, KR) 2022-11-11 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Korea Chungang Educational Foundation (Seoul, KR) 2022-11-11 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Colorcon
Moodys
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.